Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Janus kinase inhibitors, also known as JAK inhibitors or jakinibs, are a type of medication that functions by inhibiting the activity of one or more of the Janus kinase family of enzymes (JAK1, JAK2, JAK3, TYK2), thereby interfering with the JAK-STAT signaling pathway.
The report details the trend, potential and market size of Tyrosine Kinase JAK Inhibitors market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Tyrosine Kinase JAK Inhibitorsmarket, defines the market attractiveness level of Tyrosine Kinase JAK Inhibitors market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Tyrosine Kinase JAK Inhibitors industry, describes the types of Tyrosine Kinase JAK Inhibitors market, the applications of major players and the market size, and deeply analyzes the current situation of the global Tyrosine Kinase JAK Inhibitors market and the development prospects and opportunities of Tyrosine Kinase JAK Inhibitors industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Tyrosine Kinase JAK Inhibitors market in Chapter 13.
By Player:
CTI BioPharma
Sanofi
Incyte
Teva
Vertex
Eli Lilly
Galapagos
Novartis
AbbVie
Gilead
Celgene
Pfizer
Astellas Pharma
By Type:
Tofacitinib
Ruxolitinib
Baricitinib
By End-User:
Organic Chemistry Application
Biomedical Application
Other Applications
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Tyrosine Kinase JAK Inhibitors Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Tyrosine Kinase JAK Inhibitors Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Tyrosine Kinase JAK Inhibitors Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Tyrosine Kinase JAK Inhibitors Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Tyrosine Kinase JAK Inhibitors Market Analysis and Outlook to 2022
-
7.1 Global Tyrosine Kinase JAK Inhibitors Consumption (2017-2022)
-
7.2 United States Tyrosine Kinase JAK Inhibitors Consumption (2017-2022)
-
7.3 Europe Tyrosine Kinase JAK Inhibitors Consumption (2017-2022)
-
7.4 China Tyrosine Kinase JAK Inhibitors Consumption (2017-2022)
-
7.5 Japan Tyrosine Kinase JAK Inhibitors Consumption (2017-2022)
-
7.6 India Tyrosine Kinase JAK Inhibitors Consumption (2017-2022)
-
7.7 South Korea Tyrosine Kinase JAK Inhibitors Consumption (2017-2022)
8 Region and Country-wise Tyrosine Kinase JAK Inhibitors Market Analysis and Outlook to 2028
-
8.1 Global Tyrosine Kinase JAK Inhibitors Consumption Forecast (2022-2028)
-
8.2 United States Tyrosine Kinase JAK Inhibitors Consumption Forecast (2022-2028)
-
8.3 Europe Tyrosine Kinase JAK Inhibitors Consumption Forecast (2022-2028)
-
8.4 China Tyrosine Kinase JAK Inhibitors Consumption Forecast (2022-2028)
-
8.5 Japan Tyrosine Kinase JAK Inhibitors Consumption Forecast (2022-2028)
-
8.6 India Tyrosine Kinase JAK Inhibitors Consumption Forecast (2022-2028)
-
8.7 South Korea Tyrosine Kinase JAK Inhibitors Consumption Forecast (2022-2028)
9 Global Tyrosine Kinase JAK Inhibitors Market Outlook by Types and Applications to 2022
-
9.1 Global Tyrosine Kinase JAK Inhibitors Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Tofacitinib Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Ruxolitinib Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Baricitinib Consumption and Growth Rate (2017-2022)
-
9.2 Global Tyrosine Kinase JAK Inhibitors Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Organic Chemistry Application Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Biomedical Application Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Applications Consumption and Growth Rate (2017-2022)
10 Global Tyrosine Kinase JAK Inhibitors Market Outlook by Types and Applications to 2028
-
10.1 Global Tyrosine Kinase JAK Inhibitors Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Tofacitinib Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Ruxolitinib Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Baricitinib Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Tyrosine Kinase JAK Inhibitors Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Organic Chemistry Application Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Biomedical Application Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Other Applications Consumption Forecast and Growth Rate (2022-2028)
11 Global Tyrosine Kinase JAK Inhibitors Import and Export Analysis (Top 5 Countries)
-
11.1 Global Tyrosine Kinase JAK Inhibitors Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Tyrosine Kinase JAK Inhibitors Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Tyrosine Kinase JAK Inhibitors Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Tyrosine Kinase JAK Inhibitors Market Competitive Analysis
-
14.1 CTI BioPharma
-
14.1.1 CTI BioPharma Company Details
-
14.1.2 CTI BioPharma Tyrosine Kinase JAK Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 CTI BioPharma Tyrosine Kinase JAK Inhibitors Product and Service
-
14.2 Sanofi
-
14.2.1 Sanofi Company Details
-
14.2.2 Sanofi Tyrosine Kinase JAK Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Sanofi Tyrosine Kinase JAK Inhibitors Product and Service
-
14.3 Incyte
-
14.3.1 Incyte Company Details
-
14.3.2 Incyte Tyrosine Kinase JAK Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Incyte Tyrosine Kinase JAK Inhibitors Product and Service
-
14.4 Teva
-
14.4.1 Teva Company Details
-
14.4.2 Teva Tyrosine Kinase JAK Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Teva Tyrosine Kinase JAK Inhibitors Product and Service
-
14.5 Vertex
-
14.5.1 Vertex Company Details
-
14.5.2 Vertex Tyrosine Kinase JAK Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Vertex Tyrosine Kinase JAK Inhibitors Product and Service
-
14.6 Eli Lilly
-
14.6.1 Eli Lilly Company Details
-
14.6.2 Eli Lilly Tyrosine Kinase JAK Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Eli Lilly Tyrosine Kinase JAK Inhibitors Product and Service
-
14.7 Galapagos
-
14.7.1 Galapagos Company Details
-
14.7.2 Galapagos Tyrosine Kinase JAK Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Galapagos Tyrosine Kinase JAK Inhibitors Product and Service
-
14.8 Novartis
-
14.8.1 Novartis Company Details
-
14.8.2 Novartis Tyrosine Kinase JAK Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Novartis Tyrosine Kinase JAK Inhibitors Product and Service
-
14.9 AbbVie
-
14.9.1 AbbVie Company Details
-
14.9.2 AbbVie Tyrosine Kinase JAK Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 AbbVie Tyrosine Kinase JAK Inhibitors Product and Service
-
14.10 Gilead
-
14.10.1 Gilead Company Details
-
14.10.2 Gilead Tyrosine Kinase JAK Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Gilead Tyrosine Kinase JAK Inhibitors Product and Service
-
14.11 Celgene
-
14.11.1 Celgene Company Details
-
14.11.2 Celgene Tyrosine Kinase JAK Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Celgene Tyrosine Kinase JAK Inhibitors Product and Service
-
14.12 Pfizer
-
14.12.1 Pfizer Company Details
-
14.12.2 Pfizer Tyrosine Kinase JAK Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Pfizer Tyrosine Kinase JAK Inhibitors Product and Service
-
14.13 Astellas Pharma
-
14.13.1 Astellas Pharma Company Details
-
14.13.2 Astellas Pharma Tyrosine Kinase JAK Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Astellas Pharma Tyrosine Kinase JAK Inhibitors Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Tyrosine Kinase JAK Inhibitors
-
Figure Tyrosine Kinase JAK Inhibitors Picture
-
Table Global Tyrosine Kinase JAK Inhibitors Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Tyrosine Kinase JAK Inhibitors Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Tyrosine Kinase JAK Inhibitors Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Tyrosine Kinase JAK Inhibitors Consumption by Country (2017-2022)
-
Figure United States Tyrosine Kinase JAK Inhibitors Consumption and Growth Rate (2017-2022)
-
Table Europe Tyrosine Kinase JAK Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure China Tyrosine Kinase JAK Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Japan Tyrosine Kinase JAK Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure India Tyrosine Kinase JAK Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure South Korea Tyrosine Kinase JAK Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Tyrosine Kinase JAK Inhibitors Consumption Forecast by Country (2022-2028)
-
Figure United States Tyrosine Kinase JAK Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Tyrosine Kinase JAK Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Tyrosine Kinase JAK Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Tyrosine Kinase JAK Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Tyrosine Kinase JAK Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Tyrosine Kinase JAK Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Tofacitinib Consumption and Growth Rate (2017-2022)
-
Figure Global Ruxolitinib Consumption and Growth Rate (2017-2022)
-
Figure Global Baricitinib Consumption and Growth Rate (2017-2022)
-
Figure Global Organic Chemistry Application Consumption and Growth Rate (2017-2022)
-
Figure Global Biomedical Application Consumption and Growth Rate (2017-2022)
-
Figure Global Other Applications Consumption and Growth Rate (2017-2022)
-
Figure Global Tofacitinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ruxolitinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Baricitinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Organic Chemistry Application Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Biomedical Application Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Applications Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Tyrosine Kinase JAK Inhibitors Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Tyrosine Kinase JAK Inhibitors Export by Region (Top 5 Countries) (2017-2028)
-
Table CTI BioPharma (Foundation Year, Company Profile and etc.)
-
Table CTI BioPharma Tyrosine Kinase JAK Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table CTI BioPharma Tyrosine Kinase JAK Inhibitors Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Tyrosine Kinase JAK Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Tyrosine Kinase JAK Inhibitors Product and Service
-
Table Incyte (Foundation Year, Company Profile and etc.)
-
Table Incyte Tyrosine Kinase JAK Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Incyte Tyrosine Kinase JAK Inhibitors Product and Service
-
Table Teva (Foundation Year, Company Profile and etc.)
-
Table Teva Tyrosine Kinase JAK Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Tyrosine Kinase JAK Inhibitors Product and Service
-
Table Vertex (Foundation Year, Company Profile and etc.)
-
Table Vertex Tyrosine Kinase JAK Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Vertex Tyrosine Kinase JAK Inhibitors Product and Service
-
Table Eli Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly Tyrosine Kinase JAK Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Tyrosine Kinase JAK Inhibitors Product and Service
-
Table Galapagos (Foundation Year, Company Profile and etc.)
-
Table Galapagos Tyrosine Kinase JAK Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Galapagos Tyrosine Kinase JAK Inhibitors Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Tyrosine Kinase JAK Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Tyrosine Kinase JAK Inhibitors Product and Service
-
Table AbbVie (Foundation Year, Company Profile and etc.)
-
Table AbbVie Tyrosine Kinase JAK Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie Tyrosine Kinase JAK Inhibitors Product and Service
-
Table Gilead (Foundation Year, Company Profile and etc.)
-
Table Gilead Tyrosine Kinase JAK Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gilead Tyrosine Kinase JAK Inhibitors Product and Service
-
Table Celgene (Foundation Year, Company Profile and etc.)
-
Table Celgene Tyrosine Kinase JAK Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celgene Tyrosine Kinase JAK Inhibitors Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Tyrosine Kinase JAK Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Tyrosine Kinase JAK Inhibitors Product and Service
-
Table Astellas Pharma (Foundation Year, Company Profile and etc.)
-
Table Astellas Pharma Tyrosine Kinase JAK Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Astellas Pharma Tyrosine Kinase JAK Inhibitors Product and Service
-
